The Effect of Mycophenolate Mofetil Dose per Kilogram on Clinical Outcomes of Allogeneic Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide

被引：0
|
作者：
Elmariah, Hany [1 ]
Laborde, Jose [2 ]
Kim, Jongphil [2 ]
Gonzalez, Rebecca [3 ]
DiMaggio, Elizabeth [3 ]
Nishihori, Taiga [1 ]
Mishra, Asmita [1 ]
Perez, Lia Elena [1 ]
Liu, Hien [1 ]
Khimani, Farhad [1 ]
Ochoa-Bayona, Jose [1 ]
Faramand, Rawan [1 ]
Baluch, Aliyah [4 ]
Nieder, Michael L. [1 ]
Lazaryan, Aleksandr [1 ]
Sullivan, Daniel [1 ]
Pidala, Joseph A. [1 ]
Bejanyan, Nelli [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Blood & Marrow Transplantat & Cellular Immunother, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Biostat, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Pharm, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, IHM ID, Tampa, FL USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2020年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
278
引用
收藏
页码：S189 / S189
页数：1
相关论文
共 50 条
  • [1] Use of Post-Transplant Cyclophosphamide (PTCy) with Mycophenolate Mofetil and Tacrolimus in HLA Matched Allogeneic Hematopoietic Cell Transplant Is Safe and Associated with Acceptable Transplant Outcomes
    Hess, Brian T.
    Gao, Feng
    DiPersio, John F.
    Westervelt, Peter
    Vij, Ravi
    Uy, Geoffrey L.
    Stockerl-Goldstein, Keith
    Abboud, Camille N.
    Schroeder, Mark A.
    Pusic, Iskra
    Ghobadi, Armin
    Cashen, Amanda F.
    Fehniger, Todd A.
    Jacoby, Meagan A.
    Romee, Rizwan
    BLOOD, 2015, 126 (23)
  • [2] Effect of CD34+cell dose on clinical outcomes after allogeneic hematopoietic stem cell transplantation with post-transplant cyclophosphamide
    Pedraza, A.
    Salas, M. Q.
    Rodriguez-Lobato, L. G.
    Charry, P.
    Suarez-Lledo, M.
    Martinez-Cibrian, N.
    Domenech, A.
    Solano, M. T.
    Arcarons, J.
    Llobet, N.
    Cid, J.
    Lozano, M.
    Rosinol, L.
    Gutierrez-Garcia, G.
    Urbano-Ispizua, A.
    Fernandez-Aviles, F.
    Rovira, M.
    Martinez, C.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 400 - 400
  • [3] Lower Weight-Based Mycophenolate Mofetil Dosing is Associated with Superior Outcomes after Haploidentical Hematopoietic Cell Transplant with Post-transplant Cyclophosphamide
    Elmariah, Hany
    Otoukesh, Salman
    Kumar, Ambuj
    Ali, Haris
    Arslan, Shukaib
    Dimaggio, Elizabeth
    Gonzalez, Rebecca
    Shouse, Geoffrey
    Pourhassan, Hoda
    Nishihori, Taiga
    Faramand, Rawan
    Mishra, Asmita
    Khimani, Farhad
    Fernandez, Hugo
    Lazaryan, Aleksandr
    Nieder, Michael
    Perez, Lia
    Liu, Hien
    Nakamura, Ryotaro
    Pidala, Joseph
    Marcucci, Guido
    Forman, Stephen J.
    Anasetti, Claudio
    Bejanyan, Nelli
    Al Malki, Monzr M.
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (10): : 1019e1 - 1019e9
  • [4] Hyponatremia induced by post-transplant cyclophosphamide in allogeneic hematopoietic cell transplantation
    Gomez-Hernando, Marta
    Quintana, Luis F.
    Suarez-Lledo, Maria
    Martinez-Cibrian, Nuria
    Rivero, Andrea
    Ruiz-Boy, Sonia
    Carcelero, Ester
    Mate, Paula
    Riu, Gisela
    Monge, Ines
    Serrahima, Anna
    Solano, Maria Teresa
    Rosinol, Laura
    Esteve, Jordi
    Urbano-Ispizua, Alvaro
    Carreras, Enric
    Fernandez-Aviles, Francesc
    Martinez, Carmen
    Rovira, Montserrat
    Salas, Maria Queralt
    BONE MARROW TRANSPLANTATION, 2023, 58 (02) : 212 - 214
  • [5] Hyponatremia induced by post-transplant cyclophosphamide in allogeneic hematopoietic cell transplantation
    Marta Gómez-Hernando
    Luis F. Quintana
    María Suárez-Lledo
    Nuria Martínez-Cibrian
    Andrea Rivero
    Sonia Ruiz-Boy
    Ester Carcelero
    Paula Mate
    Gisela Riu
    Inés Monge
    Anna Serrahima
    Maria Teresa Solano
    Laura Rosiñol
    Jordi Esteve
    Alvaro Urbano-Ispizua
    Enric Carreras
    Francesc Fernández-Avilés
    Carmen Martínez
    Montserrat Rovira
    Maria Queralt Salas
    Bone Marrow Transplantation, 2023, 58 : 212 - 214
  • [6] Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?
    Mohty, Razan
    Al Kadhimi, Zaid
    Kharfan-Dabaja, Mohamed
    HEMATOLOGY, 2024, 29 (01)
  • [7] Post-Transplant Cyclophosphamide Equalizes Clinical Outcomes of Allogeneic Hematopoietic Cell Transplantation across Racial and Ethnic Populations
    Caprice, Teresa
    Fan, Wenyi
    Kim, Jongphil
    Faramand, Rawan
    Mishra, Asmita
    Perez, Lia
    Khimani, Farhad
    Lazaryan, Aleksandr
    Ochoa-Bayona, Jose L.
    Liu, Hien
    Jain, Michael D.
    Nieder, Michael
    Anasetti, Claudio
    Nishihori, Taiga
    Pidala, Joseph A.
    Bejanyan, Nelli
    Elmariah, Hany
    BLOOD, 2023, 142
  • [8] Predictors of fluid overload in allogeneic hematopoietic cell transplant patients receiving post-transplant cyclophosphamide
    Tsao, Megan
    Hoeg, Rasmus
    Pecoraro, Joshua
    Kuehner, Megan
    Deen, Brittany
    Guglielmo, Julie
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024,
  • [9] Nutritional Status of Allogeneic Hematopoietic Stem Cell Transplant Recipients and Post-transplant Outcomes
    Szovati, Stephanie
    Morrison, Caroline F.
    Couch, Sarah C.
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2023, 75 (04): : 1200 - 1210
  • [10] Mycophenolate mofetil and post-transplant glomerular disease
    van Gelder, T
    NEPHRON CLINICAL PRACTICE, 2004, 98 (03): : C59 - C60
12345